Principal Consultant – Clinical Data, AI & Regulatory Transformation

Company: Discover International
Apply for the Principal Consultant – Clinical Data, AI & Regulatory Transformation
Location: London
Job Description:

Principal Consultant – Clinical Data, AI & Regulatory Transformation

Life Sciences | UK

We’re looking for a consulting-led specialist to help Life Sciences clients modernise how they work across Clinical Data, AI and Regulatory transformation.

This is a role for someone who sits comfortably between strategy and delivery — able to shape client conversations, define practical roadmaps, and then get hands-on in transformation work.

You’ll work on topics such as:

  • Clinical Data / AI transformation
  • AI-enabled regulatory authoring automation
  • R&D technology transformation
  • Process, data and operating model redesign
  • Use-case shaping, solution design and implementation support

What we’re looking for

  • Strong consulting or technology-transformation background
  • Experience in Clinical Data, Regulatory, or broader R&D technology
  • Data / AI fluency, with practical understanding of how AI can be applied in regulated environments
  • Ability to support both selling and delivering work
  • Enough specialist depth to be credible with clients, while still being pragmatic and hands-on

You may be a fit if you have experience in areas like:

  • clinical data platforms, analytics or transformation
  • regulatory technology, RIM or content automation
  • AI / NLP / GenAI use cases in clinical or regulatory environments
  • digital transformation in Pharma / Biotech / CRO settings
  • consulting-led delivery across strategy, roadmap and implementation

Why this role is interesting

  • High-visibility client work at the intersection of Life Sciences, data, AI and transformation
  • Opportunity to help define how clients use AI in clinical and regulatory settings
  • Strong mix of commercial shaping and hands-on delivery
  • Specialist role with real relevance in today’s market

Posted: April 25th, 2026